Blueprint Medicines Corp (BPMC)

Industry Biotechnology

This stock can be held in an Investment ISA and an Investment Account
Sell

$98.00

Buy

$106.00

arrow-up$5.39 (+5.43%)

Blueprint Medicines Corp is a biopharmaceutical company. It is focused on improving the lives of patients with diseases driven by abnormal kinase activation. Its drug candidates include avapritinib, BLU 554, BLU-782 and BLU-667.
Prices updated at 03 May 2025, 00:38 EDT
| Prices minimum 15 mins delay
|
Prices in USD
$104.86 - $98.60
$121.90 - $73.04
-
6,757.22m
-
-
1,514,216
19.75
771,131.33
0.81
63.71m
US09627Y1091
-2.51
-
Please note that past performance is not a reliable indicator of future returns. Pre-sale Illustration.


Important Information

Please note the value of investments can go down as well as up so you may get back less than you invested. This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to an authorised financial adviser. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and(3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.
© Copyright 2025 Morningstar. All rights reserved.